Lung adenocarcinomas with HER2-activating mutations are associated with distinct clinical features and HER2/EGFR copy number gains.

Li C, Sun Y, Fang R, Han X, Luo X, Wang R, Pan Y, Hu H, Zhang Y, Pao W, Shen L, Ji H, Chen H
J Thorac Oncol. 2012 7 (1): 85-9

PMID: 22071781 · DOI:10.1097/JTO.0b013e318234f0a2

MeSH Terms (17)

Adenocarcinoma Aged DNA Mutational Analysis ErbB Receptors Female Gene Amplification Gene Dosage Humans Lung Neoplasms Male Middle Aged Mutation Rate Proto-Oncogene Proteins Proto-Oncogene Proteins p21(ras) ras Proteins Receptor, ErbB-2 Smoking

Connections (2)

This publication is referenced by other Labnodes entities:

Links